Butyrate increases glut2 mrna abundance by initiating transcription in caco2-bbe cells

Journal of Parenteral and Enteral Nutrition

Volumn 33, Issue 6, 2009, Pages 607-617

  Mangian, Heather F ^a   Tappenden, Kelly A ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Butyrate

Indexed keywords

BUTYRIC ACID; GLUCOSE TRANSPORTER 2; MESSENGER RNA;

ARTICLE; CELL DIFFERENTIATION; CELL STRAIN CACO 2; CONTROLLED STUDY; HUMAN; HUMAN CELL; INCUBATION TIME; INTESTINE ABSORPTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION INITIATION; TRANSIENT TRANSFECTION; UPREGULATION;

BUTYRATES; CACO-2 CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORTER TYPE 2; HUMANS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 70449514139     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607109336599     Document Type: Article

References (42)

1. Thorens B., Sarkar HK, Kaback HR, Lodish HF Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and beta-pancreatic islet cells. Cell. 1988 ; 55: 281-290.
2. Bell GI, Kayano T., Buse JB, et al. Molecular biology of mammalian glucose transporters. Diabetes Care. 1990 ; 13: 198-208.
3. Affleck JA, Helliwell PA, Kellett GL Immunocytochemical detection of GLUT2 at the rat intestinal brush-border membrane. J Histochem Cytochem. 2003 ; 51: 1567-1574.
4. Gouyon F., Caillaud L., Carriere V., et al. Simple-sugar meals target GLUT2 at enterocyte apical membranes to improve sugar absorption: a study in GLUT2-null mice. J Physiol. 2003 ; 552: 823-832.
5. Kellett GL, Brot-Laroche E. Apical GLUT2: a major pathway of intestinal sugar absorption. Diabetes. 2005 ; 54: 3056-3062.
6. Kellett GL, Helliwell PA The diffusive component of intestinal glucose absorption is mediated by the glucose-induced recruitment of GLUT2 to the brush-border membrane. Biochem J. 2000 ; 350: 155-162.
7. Bell GI, Kayano T., Buse JB, et al. Molecular biology of mammalian glucose transporters. Diabetes Care. 1990 ; 13: 198-208.
8. Burcelin R., Thorens B. Evidence that extrapancreatic GLUT2-dependent glucose sensors control glucagon secretion. Diabetes. 2001 ; 50: 1282-1289.
9. Burcelin R., Dolci W., Thorens B. Glucose sensing by the hepatoportal sensor is GLUT2-dependent: in vivo analysis in GLUT2-null mice. Diabetes. 2000 ; 49: 1643-1648.
10. Le Gall M., Tobin V., Stolarczyk E., Dalet V., Leturque A., Brot-Laroche E. Sugar sensing by enterocytes combines polarity, membrane bound detectors and sugar metabolism. J Cell Physiol. 2007 ; 213: 834-843.
11. Tappenden KA, Thomson AB, Wild GE, McBurney MI Short-chain fatty acid-supplemented total parenteral nutrition enhances functional adaptation to intestinal resection in rats. Gastroenterology. 1997 ; 112: 792-802.
12. Tappenden KA, McBurney MI Systemic short-chain fatty acids rapidly alter gastrointestinal structure, function, and expression of early response genes. Dig Dis Sci. 1998 ; 43: 1526-1536.
13. Tappenden KA, Drozdowski LA, Thomson AB, McBurney MI Short-chain fatty acid-supplemented total parenteral nutrition alters intestinal structure, glucose transporter 2 (GLUT2) mRNA and protein, and proglucagon mRNA abundance in normal rats. Am J Clin Nutr. 1998 ; 68: 118-125.
14. Drozdowski LA, Dixon WT, McBurney MI, Thomson AB Short-chain fatty acids and total parenteral nutrition affect intestinal gene expression. JPEN J Parenter Enteral Nutr. 2002 ; 26: 145-150.
15. Bartholome AL, Albin DM, Baker DH, Holst JJ, Tappenden KA Supplementation of total parenteral nutrition with butyrate acutely increases structural aspects of intestinal adaptation after an 80% jejunoileal resection in neonatal piglets. JPEN J Parenter Enteral Nutr. 2004 ; 28: 210-222.
16. Takeda J., Kayano T., Fukomoto H., Bell GI Organization of the human GLUT2 (pancreatic beta-cell and hepatocyte) glucose transporter gene. Diabetes. 1993 ; 42: 773-777.
17. Peterson MD, Mooseker MS Characterization of the enterocyte-like brush border cytoskeleton of the C2BBe clones of the human intestinal cell line, Caco-2. J Cell Sci. 1992 ; 102 (pt 3). 581-600.
18. Peterson MD, Bement WM, Mooseker MS An in vitro model for the analysis of intestinal brush border assembly, II: changes in expression and localization of brush border proteins during cell contact-induced brush border assembly in Caco-2BBe cells. J Cell Sci. 1993 ; 105 (pt 2). 461-472.
19. Sambuy Y., De Angelis I., Ranaldi G., Scarino ML, Stammati A., Zucco F. The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol Toxicol. 2005 ; 21: 1-26.
20. Basson MD, Beidler DR, Turowski G., et al. Effect of tyrosine kinase inhibition on basal and epidermal growth factor-stimulated human Caco-2 enterocyte sheet migration and proliferation. J Cell Physiol. 1994 ; 160: 491-501.
21. Han J., Lee HH, Kwon H., Shin S., Yoon JW, Jun HS Engineered enteroendocrine cells secrete insulin in response to glucose and reverse hyperglycemia in diabetic mice. Mol Ther. 2007 ; 15: 1195-1202.
22. Dyer J., Varro A., Dockray GJ, Shirazi-Beechey SP The expression of sugar transporters in the endocrine cell line STC-1. Biochem Soc Trans. 1997 ; 25: 478S.
23. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques. 1993 ; 15: 532-534, 536-537.
24. Latt SA, Stetten G. Spectral studies on 33258 Hoechst and related bisbenzimidazole dyes useful for fluorescent detection of deoxyribonucleic acid synthesis. J Histochem Cytochem. 1976 ; 24: 24-33.
25. Tappenden KA, McBurney MI Systemic short-chain fatty acids rapidly alter gastrointestinal structure, function, and expression of early response genes. Dig Dis Sci. 1998 ; 43: 1526-1536.
26. Tappenden KA, Drozdowski LA, Thomson AB, McBurney MI Short-chain fatty acid-supplemented total parenteral nutrition alters intestinal structure, glucose transporter 2 (GLUT2) mRNA and protein, and proglucagon mRNA abundance in normal rats. Am J Clin Nutr. 1998 ; 68: 118-125.
27. Iqbal CW, Qandeel HG, Zheng Y., Duenes JA, Sarr MG Mechanisms of ileal adaptation for glucose absorption after proximal-based small bowel resection. J Gastrointest Surg. 2008 ; 12: 1854-1864.
28. Fernandez-Mejia C., Davidson MB Effect of sodium butyrate on glucose transport and glucose-phosphorylating enzymes in RINm5F cells. Pancreas. 1993 ; 8: 589-596.
29. Houghton SG, Iqbal CW, Duenes JA, Fatima J., Kasparek MS, Sarr MG Coordinated, diurnal hexose transporter expression in rat small bowel: implications for small bowel resection. Surgery. 2008 ; 143: 79-93.
30. Rindi G., Grant SG, Yiangou Y., et al. Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice: heterogeneity of hormone expression. Am J Pathol. 1990 ; 136: 1349-1363.
31. Leibiger B., Leibiger IB Functional analysis of DNA-elements involved in transcriptional control of the human glucose transporter 2 (GLUT 2) gene in the insulin-producing cell line beta TC-3. Diabetologia. 1995 ; 38: 112-115.
32. Domon-Dell C., Wang Q., Kim S., Kedinger M., Evers BM, Freund JN Stimulation of the intestinal Cdx2 homeobox gene by butyrate in colon cancer cells. Gut. 2002 ; 50: 525-529.
33. Doenecke D., Gallwitz D. Acetylation of histones in nucleosomes. Mol Cell Biochem. 1982 ; 44: 113-128.
34. Wilson AJ, Byun DS, Popova N., et al. Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J Biol Chem. 2006 ; 281: 13548-13558.
35. Lallemand F., Courilleau D., Sabbah M., Redeuilh G., Mester J. Direct inhibition of the expression of cyclin D1 gene by sodium butyrate. Biochem Biophys Res Commun. 1996 ; 229: 163-169.
36. Barnard JA, Warwick G. Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells. Cell Growth Differ. 1993 ; 4: 495-501.
37. Schroder O., Hess S., Caspary WF, Stein J. Mediation of differentiating effects of butyrate on the intestinal cell line Caco-2 by transforming growth factor-beta 1. Eur J Nutr. 1999 ; 38: 45-50.
38. Nakano K., Mizuno T., Sowa Y., et al. Butyrate activates the WAF1/ Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J Biol Chem. 1997 ; 272: 22199-22206.
39. Sowa Y., Sakai T. Butyrate as a model for "gene-regulating chemoprevention and chemotherapy." BioFactors. 2000 ; 12: 283-287.
40. Sowa Y., Orita T., Minamikawa-Hiranabe S., Mizuno T., Nomura H., Sakai T. Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor. Cancer Res. 1999 ; 59: 4266-4270. (Pubitemid 29418741)
41. Jin B., Seong JK, Ryu DY Tissue-specific and de novo promoter methylation of the mouse glucose transporter 2. Biol Pharm Bull. 2005 ; 28: 2054-2057.
42. Laukkanen O., Lindstrom J., Eriksson J., et al. Polymorphisms in the SLC2A2 (GLUT2) gene are associated with the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study. Diabetes. 2005 ; 54: 2256-2260.